<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03021538</url>
  </required_header>
  <id_info>
    <org_study_id>17-166</org_study_id>
    <nct_id>NCT03021538</nct_id>
  </id_info>
  <brief_title>Bypass vs. Ecmo in Lung Transplantation (BELT)</brief_title>
  <acronym>BELT</acronym>
  <official_title>Randomized Clinical Trial of Intraoperative Extracorporeal Membrane Oxygenation (ECMO) Versus Cardiopulmonary Bypass (CPB) in Lung Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to compare outcomes of 2 different methods of cardiopulmonary support during
      lung transplant surgeries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will compare use of extracorporeal membrane oxygenation (ECMO) and heart-lung
      bypass (CPB) during lung transplant procedures and their short and long term outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2017</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding</measure>
    <time_frame>72 hours after surgery</time_frame>
    <description>total number of pRBC transfusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mechanical Ventilation Time (days)</measure>
    <time_frame>30 Days or discharge date (if earlier than 30 days)</time_frame>
    <description>Number of days to extubation post transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative pRBC transfusion rates</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Number of units of pRBC transfused intraoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary Graft Dysfunction</measure>
    <time_frame>72 hours</time_frame>
    <description>Graft failure or reperfusion injury measured by pgd grade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion other than pRBC</measure>
    <time_frame>72 hours</time_frame>
    <description>FFP, platelets, cryoprecipitate transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite safety outcome</measure>
    <time_frame>30 days (if earlier than 30 days)</time_frame>
    <description>30 day mortality, bleeding requiring reoperation, new ECMO, new renal failure, chronic dialysis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Lung Transplant; Complications</condition>
  <arm_group>
    <arm_group_label>Cardiopulmonary Bypass</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>There will be 40 patients placed on cardiopulmonary bypass during lung transplantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extracorporeal Membrane Oxygenation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>There will be 40 patients placed on ECMO during lung transplantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal Membrane Oxygenation</intervention_name>
    <description>ECMO is used during lung transplant procedure</description>
    <arm_group_label>Extracorporeal Membrane Oxygenation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiopulmonary Bypass</intervention_name>
    <description>CPB is used during lung transplant procedure</description>
    <arm_group_label>Cardiopulmonary Bypass</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. The study population will be all patients requiring cardiopulmonary support while
        undergoing lung transplantation at our institution.

        Exclusion Criteria:

          1. Patients undergoing concomitant cardiac operations with indication for obligate use of
             cardiopulmonary bypass

          2. Patient with specific anatomy that require full cardiac decompression such as severe
             pulmonary hypertension or large heart that are shifted severely into the left chest

          3. Patients with high likelihood of significant pleural bleeding that will require
             returning the blood back into the cardiotomy reservoir

          4. Patients bridged to transplant with ECMO

          5. Cystic fibrosis/bronchiectasis/resistant infection patients where surgeon will need to
             remove both lungs prior to implantation

          6. Patients who the surgeon feels would be better served with CPB rather than ECMO- These
             patients will be entered into a registry and followed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Tong, M.D., M.B.A.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Tong, M.D., M.B.A.</last_name>
    <phone>216-445-0807</phone>
    <email>tongz@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Zhen Tong, MD</last_name>
      <phone>216-445-0807</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hoechter DJ, von Dossow V, Winter H, MÃ¼ller HH, Meiser B, Neurohr C, Behr J, Guenther S, Hagl C, Schramm R. The Munich Lung Transplant Group: Intraoperative Extracorporeal Circulation in Lung Transplantation. Thorac Cardiovasc Surg. 2015 Dec;63(8):706-14. doi: 10.1055/s-0035-1556873. Epub 2015 Aug 20.</citation>
    <PMID>26291747</PMID>
  </reference>
  <reference>
    <citation>Ius F, Kuehn C, Tudorache I, Sommer W, Avsar M, Boethig D, Fuehner T, Gottlieb J, Hoeper M, Haverich A, Warnecke G. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012 Dec;144(6):1510-6. doi: 10.1016/j.jtcvs.2012.07.095. Epub 2012 Aug 31.</citation>
    <PMID>22944092</PMID>
  </reference>
  <reference>
    <citation>Bermudez CA, Shiose A, Esper SA, Shigemura N, D'Cunha J, Bhama JK, Richards TJ, Arlia P, Crespo MM, Pilewski JM. Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation. Ann Thorac Surg. 2014 Dec;98(6):1936-42; discussion 1942-3. doi: 10.1016/j.athoracsur.2014.06.072. Epub 2014 Oct 22.</citation>
    <PMID>25443002</PMID>
  </reference>
  <reference>
    <citation>Machuca TN, Collaud S, Mercier O, Cheung M, Cunningham V, Kim SJ, Azad S, Singer L, Yasufuku K, de Perrot M, Pierre A, McRae K, Waddell TK, Keshavjee S, Cypel M. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg. 2015 Apr;149(4):1152-7. doi: 10.1016/j.jtcvs.2014.11.039. Epub 2014 Nov 21.</citation>
    <PMID>25583107</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2017</study_first_submitted>
  <study_first_submitted_qc>January 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2017</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Michael Zhen-Yu Tong, MD</investigator_full_name>
    <investigator_title>Cardiac Surgeon</investigator_title>
  </responsible_party>
  <keyword>Cardiopulmonary Bypass</keyword>
  <keyword>Extracorporeal Membrane Oxygenation</keyword>
  <keyword>Primary Graft Dysfunction</keyword>
  <keyword>Hemorrhage</keyword>
  <keyword>Mechanical Ventilator</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

